CeifiT gained distribution rights to distribute RevVac safety syringe in Israel, Jordan, the United Arab Emirates and Qatar, under the terms of agreement.

As per the exclusivity right, CeifiT should distribute a minimum of 3,000,000 units per quarter of the RevVac safety syringe.

The RevVac auto retractable vacuum safety syringe utilizes a patented technology in which a vacuum causes the needle to retract into the barrel of the syringe or device after an injection is administered or blood is drawn.

Revolutions Medical CEO and chairman Ron Wheet said RevVac safety syringe offers reductions of contaminated needles risks and also eliminates accidental needle sticks.